Journal articleJACC Cardiovasc Interv · July 27, 2026
BACKGROUND: The optimal antithrombotic strategy after valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) for degenerated aortic bioprostheses remains undetermined, and current practice patterns in the United States are not well characterize ...
Full textLink to itemCite
Journal articleStruct Heart · May 2026
BACKGROUND: Functional mitral regurgitation (FMR) is associated with poor heart failure (HF) outcomes. Mitral transcatheter edge-to-edge repair (M-TEER) is recommended for symptomatic patients despite medical therapy, though the influence of sex and race o ...
Full textLink to itemCite
Journal articleJAMA Cardiol · March 1, 2026
IMPORTANCE: Recent evidence suggests that hospital-level associations between procedural volume and outcomes for transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER) may be plateauing. Less is known about the o ...
Full textLink to itemCite
Journal articleEur Heart J · February 9, 2026
BACKGROUND AND AIMS: Radial access site for percutaneous coronary intervention (PCI) is recommended by clinical practice guidelines because of superior outcomes compared with femoral access site. Historically, the adoption of radial access site in the USA ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Interv · February 2026
BACKGROUND: Heart failure (HF) remains a significant burden following transcatheter aortic valve replacement, adversely impacting survival and quality of life. Identification of patients who may benefit from closer monitoring or adjunctive medical therapy ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Interv · January 2026
BACKGROUND: Current national performance metrics rank transcatheter aortic valve replacement (TAVR) centers based on risk-adjusted outcomes. This could make operators/centers less inclined to offer TAVR in high-risk cases. METHODS: We used simulation model ...
Full textLink to itemCite
Journal articleCirculation · April 22, 2025
BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of measuring the quality of clinical technology adoption. MET ...
Full textLink to itemCite
Journal articleJAMA Cardiol · December 1, 2024
IMPORTANCE: Although transcatheter aortic valve replacement (TAVR) outcomes in the US have improved substantially since 2011, it is unknown whether these trends have continued since 2019. OBJECTIVE: To examine changes in risk-adjusted TAVR outcomes from 20 ...
Full textLink to itemCite
Journal articleWest J Emerg Med · November 2024
INTRODUCTION: Pain is a major driver of visits to the emergency department (ED). Clinicians must consider not only the efficacy of treatment options but also subsequent healthcare utilization and patient-centered outcomes such as side effects from prescrib ...
Full textLink to itemCite
Journal articleCirculation. Cardiovascular interventions · August 2024
BackgroundFailure to rescue (FTR) describes in-hospital mortality following a procedural complication and has been adopted as a quality metric in multiple specialties. However, FTR has not been studied for percutaneous coronary intervention (PCI) ...
Full textCite
Journal articleCirc Cardiovasc Interv · July 2024
BACKGROUND: Elevated aortic valve gradients are common after transcatheter aortic valve implantation for degenerated surgical aortic valve replacement bioprostheses, but their clinical impact is uncertain. METHODS: A total of 12 122 patients who underwent ...
Full textLink to itemCite
Journal articleBMC Health Serv Res · May 24, 2024
BACKGROUND: Healthcare facility characteristics, such as ownership, size, and location, have been associated with patient outcomes. However, it is not known whether the outcomes of healthcare workers are associated with the characteristics of their employi ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Interv · April 2024
BACKGROUND: Transcatheter edge-to-edge mitral valve (MV) repair (TEER) is an effective treatment for patients with primary mitral regurgitation at prohibitive risk for surgical MV repair (MVr). High-volume MVr centers and high-volume TEER centers have bett ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Interv · February 26, 2024
BACKGROUND: A single, multitiered valve center designation has been proposed to publicly identify centers with expertise for all valve therapies. The correlation between transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge re ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Interv · February 12, 2024
BACKGROUND: Although permanent pacemaker (PPM) implantation is a common complication of transcatheter aortic valve replacement (TAVR), hospital variation and change in PPM implantation rates are ill defined. OBJECTIVES: The aim of this study was to determi ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Interv · November 13, 2023
BACKGROUND: Little is known about the outcomes of transcatheter aortic valve replacement (TAVR) in minimally symptomatic patients. OBJECTIVES: The authors aimed to evaluate the outcomes of patients with minimally symptomatic severe aortic stenosis treated ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Interv · July 2023
BACKGROUND: Over the past decade, there has been substantial improvement in outcomes after transcatheter aortic valve replacement. Many patient and procedural factors have also changed over that time, making it challenging to untangle the drivers of those ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Interv · June 26, 2023
BACKGROUND: Contemporary data comparing the outcomes of transradial access (TRA) vs transfemoral access (TFA) among patients presenting with acute myocardial infarction and cardiogenic shock (AMI-CS) undergoing percutaneous coronary intervention (PCI) are ...
Full textLink to itemCite
Journal articleJAMA Cardiol · September 1, 2022
IMPORTANCE: In the setting of uncertain efficacy and additional, unreimbursed cost, use of an embolic protection device (EPD) during transcatheter aortic valve replacement (TAVR) has had variable uptake. The Centers for Medicare & Medicaid Services (CMS) i ...
Full textLink to itemCite
Journal articleEur Heart J Qual Care Clin Outcomes · March 2, 2022
AIMS: In contrast to patient-reported health status measures (such as the Kansas City Cardiomyopathy Questionnaire), the New York Heart Association class is based on a physician's assessment of heart failure symptoms and functional limitations on behalf of ...
Full textLink to itemCite
Journal articleWest J Emerg Med · January 18, 2022
INTRODUCTION: Millions of people present to the emergency department (ED) with chest pain annually. Accurate and timely risk stratification is important to identify potentially life-threatening conditions such as acute coronary syndrome (ACS). An ED-based ...
Full textOpen AccessLink to itemCite
Journal articleAnn Thorac Surg · January 2022
Data for nearly all patients undergoing transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) with an approved device in the United States is captured in the Society of Thoracic Surgeons/American College of Cardiology T ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Interv · January 2022
BACKGROUND: There are limited contemporary, national data describing diagnostic cardiac catheterization with subsequent percutaneous coronary intervention (ad hoc percutaneous coronary intervention [PCI]) performed by an invasive-diagnostic and interventio ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · December 7, 2021
Data for nearly all patients undergoing transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) with an approved device in the United States is captured in the Society of Thoracic Surgeons/American College of Cardiology T ...
Full textLink to itemCite
Journal articleWest J Emerg Med · September 23, 2021
INTRODUCTION: Emergency departments (ED) use many medications with a range of therapeutic efficacy and potential significant side effects, and many medications have dosage adjustment recommendations based on the patient's specific genotype. How frequently ...
Full textOpen AccessLink to itemCite
Journal articleCirculation · July 20, 2021
BACKGROUND: Transcatheter aortic valve replacement (TAVR) is a transformative therapy for aortic stenosis. Despite rapid improvements in technology and techniques, serious complications remain relatively common and are not well described by single outcome ...
Full textLink to itemCite
Journal articleThe American journal of emergency medicine · July 2021
BackgroundPain can impair functional status, including a patient's ability to return to work. The purpose of this study was to determine whether there was an association between pain levels and return-to-work status during the first 4 days post-ED ...
Full textCite
Journal articleEur Heart J Qual Care Clin Outcomes · March 15, 2021
AIMS: While complications of transcatheter aortic valve replacement (TAVR) have decreased, they still occur commonly and may negatively impact both short- and long-term outcomes. We sought to examine the association of complications after TAVR with surviva ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Qual Outcomes · March 2021
BACKGROUND: Health status assessment is essential for documenting the benefit of transcatheter aortic valve replacement (TAVR) or transcatheter mitral valve repair on patients' symptoms, function, and quality of life. Health status can also be a powerful m ...
Full textLink to itemCite
Journal articleWest J Emerg Med · August 21, 2020
INTRODUCTION: Triage functions to quickly prioritize care and sort patients by anticipated resource needs. Despite widespread use of the Emergency Severity Index (ESI), there is still no universal standard for emergency department (ED) triage. Thus, it can ...
Full textOpen AccessLink to itemCite
Journal articleJACC Cardiovasc Interv · June 8, 2020
OBJECTIVES: This paper details trends and outcomes in U.S. patients undergoing transcatheter aortic valve replacement (TAVR) who present pre-procedurally with cardiogenic shock. BACKGROUND: Demographic, procedural characteristics, and clinical outcomes in ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Interv · June 8, 2020
OBJECTIVES: The aims of this study were to examine variation in the use of conscious sedation (CS) for transcatheter aortic valve replacement (TAVR) across hospitals and over time and to evaluate outcomes of CS compared with general anesthesia (GA) using i ...
Full textLink to itemCite
Journal articleAnn Thorac Surg · June 2020
BACKGROUND: Due to perceived technical challenges, patients with previous surgical mitral valve repair or replacement (SMVR) have been excluded from most transcatheter aortic valve replacement (TAVR) trials. Our objective was to compare the 30-day and 1-ye ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · December 17, 2019
BACKGROUND: Transcatheter mitral valve repair (TMVr) for the treatment of mitral regurgitation (MR) is a complex procedure that requires development of a unique skillset. OBJECTIVES: The purpose of this study was to examine the relationship between operato ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Interv · September 23, 2019
OBJECTIVES: The aim of this study was to evaluate the incidence and outcomes of surgical bailout during transcatheter aortic valve replacement (TAVR). BACKGROUND: The incidence and outcomes of unplanned conversion to open heart surgery, or "surgical bailou ...
Full textLink to itemCite
Journal articleJAMA · June 18, 2019
IMPORTANCE: Reducing postprocedural stroke is important to improve the safety of transcatheter aortic valve replacement (TAVR). OBJECTIVE: This study evaluated the trends of stroke occurring within 30 days after the procedure during the first 5 years TAVR ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Interv · February 25, 2019
OBJECTIVES: The aim of this study was to evaluate the association between pre-procedural left ventricular hypertrophy (LVH) patterns and clinical outcomes after transcatheter aortic valve replacement (TAVR). BACKGROUND: The association between pre-procedur ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Interv · February 2019
BACKGROUND: Renal disease is associated with poor prognosis despite guideline-directed cardiovascular therapy, and outcomes by sex in this population remain uncertain. METHODS AND RESULTS: Patients (n=5213) who underwent a MitraClip procedure in the Nation ...
Full textLink to itemCite
Journal articleJAMA · December 4, 2018
IMPORTANCE: Data are lacking on the effect of a renin-angiotensin system (RAS) inhibitor prescribed after transcatheter aortic valve replacement (TAVR). Treatment with a RAS inhibitor may reverse left ventricular remodeling and improve function. OBJECTIVE: ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Interv · October 2017
BACKGROUND: Peripheral artery disease (PAD) is associated with increased cardiovascular mortality, and PAD risk factors overlap with those for aortic stenosis. The prevalence and outcomes associated with PAD in a population undergoing transcatheter aortic ...
Full textLink to itemCite
Journal articleJ Am Heart Assoc · August 21, 2017
BACKGROUND: Nearly 17% of patients are readmitted within 30 days of discharge after transcatheter aortic valve replacement. Selected patients are discharged to skilled nursing facilities, yet the association between a hospital's practice to discharge home ...
Full textLink to itemCite
Journal articleJournal of Nepal Health Research Council · January 2016
BackgroundAssessing health status is crucial to understand the level of health in the community. Maternal health, child health and behavioral practice on diseases are key issues to assess health status of a community in Nepal. Nationwide surveys a ...
Cite